YUTIQ (nda210331)- (0.18MG)

Generic Name	FLUOCINOLONE ACETONIDE	Innovator	ALIMERA SCIENCES INC
Dosage	0.18MG
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2028-Jan-12	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2021-Nov-12
GAIN Expiry	None	Drug Complexity	No
Indication	YUTIQ contains a corticosteroid and is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
0.18MG	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of YUTIQ